Flex Funds A

Clinical trial (according to AMG or MPG or non-AMG/non-MPG)

Manufacturing and quality control of product candidates (e.g. vaccines, biologics, drugs) under pre-GMP and GMP conditions

Development of novel diagnostic, preventive and therapeutic measures (excluding biomarker discovery, target validation and initial hit screening)

Preclinical studies (e.g. absorption, distribution, metabolism, excretion (ADME), safety pharmacology and toxicity testing) as well as preclinical proof-of-concept studies

Seed grant funding for new and innovative project ideas addressing the FlexFunds topics 1-4. Applicants may request up to 100.000 € for a period not to exceed 12 months.